'FLARE' of tumor marker in advanced gastric cancer treated with first-line systemic therapy.

Zhang, Fangyuan; Zhai, Menglan; Yang, Jinru; Zhao, Lei; Lin, Zhenyu; Wang, Jing; Zhang, Tao; Yu, Dandan

Zhang, Fangyuan; Zhai, Menglan; Yang, Jinru; Zhao, Lei; Lin, Zhenyu; Wang, Jing; Zhang, Tao; Yu, Dandan.

Affiliation

Zhang F; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhai M; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yang J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhao L; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lin Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang J; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yu D; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Therap Adv Gastroenterol ; 15: 17562848221124029, 2022.

Article in En | MEDLINE | ID: mdl-36187367

Key words

CA125; CA19-9; CEA; FLARE; gastric cancer; prognosis; tumor marker

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Therap Adv Gastroenterol Year: 2022 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google